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Summary Background/objectives. Environmental exposure and personal susceptibility both
contribute to the development of hand eczema. In this study, we investigated the effect
of loss-of-function mutations in the filaggrin gene (FLG), atopic dermatitis and wet work
exposure on the development of hand eczema in apprentice nurses.
Methods. Dutch apprentice nurses were genotyped for the four most common FLG
mutations; atopic dermatitis and hand eczema history were assessed by questionnaire.
Exposure and hand eczema during traineeships were assessed with diary cards.
Results. The prevalence of hand eczemaduring traineeshipswas higher among subjects
with a history of hand eczema reported at inclusion. Hand washing during traineeships
andathome increased the risk of handeczema.After adjustment for the effects of exposure
andFLGmutations, an odds ratio of 2.5 (90% confidence interval 1.7–3.7)was found for
a history of atopic dermatitis. In this study, an increased risk of hand eczema conferred by
FLG mutations could not be shown, but subjects with concomitant FLG mutations and
atopic dermatitis showed the highest risk of hand eczema during traineeships.
Conclusion. A history of atopic dermatitis, a history of hand eczema and wet work
exposure were the most important factors increasing the risk of hand eczema during
traineeships.
Key words: atopic dermatitis; filaggrin; hand eczema; nurses; occupational diseases;
susceptibility.
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Hand eczema (HE), as a manifestation of contact
dermatitis of the hands, is one of the most common
occupationaldiseases in industrializedcountries,andmay
account for up to 90% of all occupational skin diseases
(1, 2). Skin exposure to irritants is a risk in occupations
suchasnursing,hairdressing, andmetalworking; in these
occupations, 1-year prevalence rates of HE of up to 30%
have been reported (3–7). Although relevant exposure
is a prerequisite for the development of occupational
HE, some workers are more susceptible than others. The
best-known and firmly established susceptibility factor
for the development of occupational HE is a history of
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd. 139
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium,
provided the original work is properly cited.
SUSCEPTIBILITY TO HAND ECZEMA IN APPRENTICE NURSES • VISSER ET AL.
atopic dermatitis (AD). The increased risk of developing
occupational HE for individuals with a history of AD
has long been recognized (8–10), and recent population
studies reported up to fivefold increased risks (11–13).
One of the possible causes of the risk-enhancing effect of
AD is an impaired skin barrier. Experimental studies have
shown that thebarrier functionof the skinof patientswith
AD is reduced as compared with healthy controls, even
in uninvolved skin areas (14–16). The mechanisms that
underlie reduced skin barrier function in AD are not fully
clear, but recent research suggests that the epidermal
protein filaggrinmight play an important role (17, 18). In
the stratum corneum, filaggrin contributes to structural
strength by aggregating the keratin filaments, and its
breakdownproducts support hydration, pHbalance, anti-
bacterial defence, and resistance to ultraviolet radiation
(18, 19). Several loss-of-function mutations have been
identified in the filaggrin gene (FLG), resulting in reduced
amounts or, in the case of homozygotes, in the absence
of filaggrin in the skin. The summed prevalence of
individuals who carry one or more of the most common
FLG loss-of-function mutations in European populations
is reported to be 7–10% (17, 20–23). The impact of
these mutations on skin barrier function has been shown
in animal models (24), in patients with ichthyosis or
AD (14, 25), and in 3-month old infants with and
without eczema (26). FLG loss-of-function mutations are
strongly associated with AD; 16–44% of individuals with
moderate to severe AD carry one or more FLGmutations
(20, 22, 27–29). A recent meta-analysis revealed amore
than threefold increased risk of developing AD in carriers
of either one of the R501X or 2282del4 mutations
(30). Because filaggrin is important for the barrier
function of the skin, it is plausible that FLG mutations
as such can increase the risk of occupational HE. Indeed,
recent case–control studies foundanassociation between
FLG mutations and the occurrence of occupational HE
(31–34). In the aetiological relationship between FLG
mutations and occupational HE, AD can be both an
intermediate factor (as FLG mutations increase the risk
of AD) and a co-determinant independent from FLG. In
the present study, we aimed to gain more insight into the
relative contributions of both FLG mutations and AD to
the aetiology of occupational HE.
Knowledge of susceptibility factors could contribute to
more targeted prevention of occupational HE. In some
countries, a history of HE and a history of AD are used to
identify persons at risk in jobs with high skin exposure;
susceptibleworkers are offered extra preventivemeasures
and attention by their occupational physician (35, 36). It
has not yet been investigated whether the predictive
value of susceptibility screening can be increased by
adding a genetic susceptibility marker such as FLG
mutations. Interestingly, 40% of FLG mutation carriers
do not develop AD (19, 37, 38). This subgroup will
not be recognized as susceptible in current prevention
programmes. Another issue is that most of the studies
that have explored the effect of FLGmutations on contact
dermatitis (31–33, 39–41) have not accounted for the
extent of environmental exposure. Therefore, the relative
contributions ofFLGmutations andahistory of or current
AD, taking exposure into consideration, are still to be
elucidated. We performed a prospective cohort study
among apprentice nurses, who provided a DNA sample
by buccal swab, filled in a questionnaire concerning
symptoms of AD and atopy, and were consecutively
followed up for 1–3 years, with regular monitoring of
symptoms of HE as well as exposure to ‘wet work’ as
assessed with diary cards. The general characteristics of
this cohort, the exposure to wet work during follow-up
and the occurrence of HE have been described in Part I of
this study (42). The present article describes the influence
of FLG mutations, AD and exposure on the risk of HE in
this cohort.
Methods
Subjects
A detailed description of the study population and
inclusion procedure is provided in Part I of this study
(42). In short, apprentices were recruited from 15
different Dutch vocational schools that prepare students
for a career in healthcare (nursing or care-giving).
Students were eligible for participation if they had
recently started a traineeship with a duration of at
least 10weeks, or were expecting to do so within the
next few weeks. The only exclusion criterion was the
presence of chronic inflammatory disease (e.g. psoriasis
or rheumatoid arthritis). Approval was obtained from
the Medical Ethical Committee of the Academic Medical
Centre, Amsterdam, The Netherlands.
DNA sampling and genotyping
The four most common FLG loss-of-function mutations
in European populations were genotyped: R501X,
2282del4, R2447X, and S3247X. Subjects provided a
buccal swab sample (Geneticlab Diagnostic & Research,
Pordenone, Italy; http://www.geneticlab.it), and DNA
material was obtained from buccal mucosa cells. For
each subject, two swabs were obtained, and 2ml
of lysis buffer (Puregene® Cell Lysis Solution; Gen-
tra Systems, Minneapolis, MN, USA) was added to
each swab to disrupt the cells and stabilize the DNA.
Extraction andgenotyping for theFLGmutationsR501X,
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
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R2447X and S3247X was performed by KBioscience
(http://www.kbioscience.co.uk). Genotyping was per-
formed with the KASP single-nucleotide polymorphism
genotyping system, a homogeneous fluorescence reso-
nance energy transfer (FRET)-based system, coupledwith
competitive allele-specific polymerase chain reaction
(PCR). Blind duplicates and Hardy–Weinberg equilib-
rium tests were used as quality control tests. R501X was
genotyped by using the primer pair GAATGCCTGGAGCT
GTCTCG (C-allele) and CTGAATGCCTGGAGCTGTCTCA
(T-allele), with the common allele primer GCACTGGAG
GAAGACAAGGATCG. R2447X was genotyped by using
the primer pair GAGTGCCTGGAGCTGTCTCG (C-allele)
and GAGTGCCTGGAGCTGTCTCA (T-allele), with the
common allele primer GAGGAAGACAAGGATCCCAC
CACA. S3247X was genotyped by using the primer pair
GTGTCTGGAGCCGTGCCTTG (C-allele) and GGTGTCTG
GAGCCGTGCCTTT (A-allele), with the common primer
CTTCCAGAAACCATCGTGGATCTGT. Genotyping for
2282del4was performed by sizing a fluorescently labelled
PCR fragment on an Applied Biosystems 3100 or 3730
DNA sequencer (Foster City, CA, USA), as described
previously (32, 43).
Questionnaires
At inclusion, subjects filled in a questionnaire including
items on eczema, rhinitis, conjunctivitis and asthma,
allergies and/or symptoms following exposure to dust,
animals, pollen, foods, metals, and wool, present or
past skin diseases, the presence of any other chronic
disease, medication use, present or past skin symptoms
on the hands or fingers, and exposure to wet work during
previous jobs/apprenticeships, secondary jobs, and leisure
or household activities. Atopywas defined as the presence
of two or more of the following: symptoms following
exposure to common allergens, rhinitis, conjunctivitis, or
asthma. ADwas assessed according to a slightly modified
version of the UKWorking Party criteria ‘questions only’
definition, in which onset below 2 years of age was
replaced by onset below 5 years of age as a proxy of
‘childhood dermatitis’.
At the end of the follow-up period, an email
questionnaire was sent to all subjects still in the study.
This final questionnaire included items on symptoms
experienced during follow-up, consultation of general
practitioners or dermatologists, changes in hand hygiene
behaviour, the use of protective hand cream, information
on traineeships and side jobs, and smoking.
Exposure and symptoms during practical training
During their traineeships, the students had to keep count
of the wet work activities that they performed during
several shifts, using special diary cards as described in
detail in Part I of this study (42). Skin symptoms on the
hands were also recorded on the cards. If no cards had
been returned near the end of the traineeship, students
were contacted by email and/or telephone to retrieve
information about the type of traineeship and possible
symptoms retrospectively.
Following the classification for screening for HE
symptoms proposed by Vermeulen et al. (44), HE was
defined as the presence of at least one of the following
symptoms of combinations: fissures and redness, fissures
and itch, fissures and scaling, vesicles, or papules, plus
duration of >3 days or recurrence (symptoms reported
more than once). As these criteria were originally
developed for identifying cases of HE in a working
population, we were concerned that, by using this
definition, wewouldmiss early-stage symptoms thatmay
progress into HE. Therefore, we also used a more lenient
definition, ‘mildHE’, defined as the presence of at least one
of the following symptoms or combinations: redness and
itch, redness and scaling, itch and scaling, fissures and
redness, fissures and itch, fissures and scaling, vesicles, or
papules, all irrespective of duration or recurrence.
Without specification, HE refers to any episode of HE
during follow-up. Some analyses comprise students with-
out a history of HE in contrast to students with a history
of HE. The latter refers toHE at any time before or at inclu-
sion. A first episode of HE during follow-up in a student
without a history of HE is equivalent to ‘incident HE’.
Statistical analysis
Statistical analysis was performed with ibm spss™ statis-
tics version 19 and Microsoft Excel™. In the subgroup
analyses,FLGmutation carrierswere comparedwithFLG
wild-type individuals. No distinction was made between
homozygous, compound heterozygous or heterozygous
FLGmutation carriers, because the subgroup of homozy-
gous or compound heterozygous carriers was too small
for subgroup analysis to be performed. Because AD can
be both an intermediate factor and an independent
co-determinant in the aetiological relationship between
FLGmutations andHE,we chose to use stratified analyses
to study the effects on HE of FLGmutations and AD, each
in the absence and in the presence of the other factor.
The relative risks (RRs) and confidence intervals
(CIs) for the subgroup analyses of HE symptoms
reported at inclusion were computed by using
cross-tabulated results and applying the following
formulas in Excel: RR= [a/(a+ b)]/[c/(c+ d)], with
a and c being the numbers of HE cases in the
‘exposed’ and ‘referent’ groups, respectively; and 90%
CI(RR)= exp{ln(RR)±1.645*SE[ln(RR)]}, in which
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
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SE[ln(RR)]= sqrt{b/[a(a+ b)]+ d/[c(c+ d)]}. The 90% CI
corresponds to one-sided testing with p<0.05.
Analysis of the combined influence of susceptibility
and exposure factors on the risk of HE during follow-up
was performed with generalized linear mixed models in
spss. HE is a disease with a fluctuating course, and the
recovery time may be as short as a few days. Thus, the
apprentice nurses would have time to recover from HE in
between traineeship periods. We therefore assumed that
the probability of developing HE in one traineeship does
not depend on the extent of exposure or on having hadHE
in previous traineeships. Each traineeship was therefore
counted as a separate entity, and data from subjects who
entered a second or a third traineeship were entered as
multiple records in the database. This, however, results in
theproblemthat, regardless of susceptibility, subjectswho
contributed data for multiple traineeships would have
hadmore opportunities to developHE than thosewhohad
been followed for only one traineeship. Therefore, amixed
models design was used in the analyses, with participant
ID included as random effect (procedure GENLINMIXED
in spss™). In such a mixed model, the within-subject
correlation is taken into account.
Analysisofwetworkexposure inthiscohort (Part I)had
shown that a frequency of handwashing during practical
training of >8 times per shift, hand washing at home
>10 times per day and working in a side job involving
wet work for >8hr a week increased the risk of HE (Part
I) (42). Therefore, thesewere included as binary variables
in the multivariate mixed models to represent wet work
exposure. Preceding this analysis, the mean frequency
of hand washing in different healthcare sectors was
assessed with linear mixed models with healthcare sector
as fixed effect and subject identification as random effect
(procedureMIXED in spss™). Themean frequencyofhand
washingduringtraineeshipswas lowest inpsychiatry (7.0
timesper shift),mediumtohigh inhomecareandhospitals
(8.8 and 8.9 times per shift, respectively), highest in care
for the disabled and nursing homes (10.4 and 10.5 times
per shift, respectively). The frequency of hand washing
during traineeships was classified according to whether
the traineeship was performed in psychiatry or in any
other sector, which corresponds to a cut-off value of
(supposedly) 8 times per shift. This classification was
applied to all subjects.
Use of hand cream, exposure to wet work and number
of subjects reporting HE during traineeships (Fig. 2) was
compared between the four subgroups categorized byFLG
and AD by use of the chi-square test.
Results
Study population
The participation rate of the apprentices invited was
∼50%. A total of 728 apprentice nurses completed the
inclusionquestionnaire. Sevenapprenticeswere excluded
because of chronic inflammatory disease. Some subjects
didnotprovideabuccal swabsampleat inclusion,because
they were aged <18 years (in The Netherlands, these
persons are only allowed to provide a DNA sample with
parentalconsent),andDNAsamplingwaspostponeduntil
parental consent was obtained or until they had turned
18 years during follow-up. Eventually, a total of 626DNA
samples were obtained, 596 of which were successfully
genotyped for all four investigated FLG loss-of-function
mutations (R501X, 2282del4, R2447X, and S3247X).
A further 150 subjects were lost to follow-up shortly
after completion of the inclusion questionnaire or quit the
study before going through a traineeship (mostly because
of changing career), leaving a total of 446 subjects in
whom to study the impact of susceptibility factors on the
risk of developing HE during vocational training.
Genotype distributions and associations with atopic
disease
Table 1 shows the genotype distributions. FLGmutations
were present in11.1%of the subjects. Fifty-six individuals
were heterozygous for onemutation, 2were homozygous
for2282del4, 3werehomozygous forR2447X, and1was
compound heterozygous for 2282del4 and R501X.
Table 1. Genotype distributions for the filaggrin gene FLG loss-of-functionmutations R501X, 2282del4, R2447X and S3247X in apprentice
nurses
FLG mutation R501X 2282del4 R2447X S3247X Combined (four mutations)
Group size 608 614 610 607 596
AA, n (%) 587 (96.5) 576 (93.8) 604 (99.0) 605 (99.7) 530 (88.9)
Aa, n (%) 21 (3.5) 35 (5.7) 3 (0.5) 2 (0.3) 59 (9.9)
aa, n (%) 0 (0) 3 (0.5) 3 (0.5) 0 (0) 7 (1.2)
Total FLG carriers (Aa+ aa), n (%) 21 (3.5) 38 (6.2) 6 (1.0) 2 (0.3) 66 (11.1)
Wild-type allele frequency (%) 98.3 96.7 99.3 99.8 93.9
Mutant allele frequency (%) 1.7 3.3 0.7 0.2 6.1
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
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The genotype distributions were not in Hardy–
Weinberg equilibrium for 2282del4, R2447X, and the
combined genotype. This was probably because of the
relatively large number of homozygotes among subjects
with AD, combined with a slight overrepresentation
of subjects with AD in this cohort (see Part I) (42). In
subjects without AD (n=460), the genotype distribu-
tions for 2282del4 and the combined genotype were in
Hardy–Weinberg equilibrium.
FLG mutations were associated with a history of
AD (RR 1.8; 90% CI 1.37–2.35), especially with
persistentADstartingbefore5 yearsofageandstillpresent
at the time of inclusion (RR 2.6; 90% CI 1.43–4.67).
There were also associations between FLGmutations and
generaldryskin (RR2.5;90%CI1.82–3.38)andbetween
FLGmutations and symptoms upon exposure to common
allergens (RR 1.3; 90% CI 1.01–1.54). No association
was found with rhinitis or asthma.
Symptoms of HE reported at inclusion
Weused stratified analyses to investigate the effect of FLG
mutations and AD on the occurrence of HE. The study
population was divided into four groups: (i) subjects
without FLG mutations and with no history of AD
(FLG−/AD−); (ii) subjects with FLG mutations but with
no history of AD (FLG+/AD−); (iii) subjects without FLG
mutations but with a history of AD (FLG−/AD+); and
(iv) subjects with both FLGmutations and a history of AD
(FLG+/AD+). In a retrospective approach, we compared
past and present symptoms ofHE reported in the inclusion
questionnaire between these four groups (Table 2). In
total, 54% of all subjects reported one or more skin
symptoms, 13%had ahistory ofHE, and7%hadHEat the
time of inclusion. Regardless of FLGmutations, a history
of AD conferred an increased RR for all investigated
symptoms. Subjects with concomitant FLG mutations
and AD (FLG+/AD+) showed the highest symptom
prevalence, and a significantly higher prevalence of
scaling, fissures and current HE than the FLG−/AD+
subgroup. Among subjects without a history of AD, those
who carried one ormoreFLGmutations (FLG+/AD−) did
not reportmore symptoms on the hands and fingers orHE
before or at inclusion than those without FLGmutations.
Of the 7 homozygous or compound heterozygous
subjects among the FLG mutation carriers, 6 had a
history of AD, 3 had HE at the time of inclusion, and
another 3 reported a history of HE.
HE during traineeships: effects of AD, FLG mutations,
and wet work
One to three years of follow-up was completed for 446
subjects. One hundred and thirty subjects (29%) reported
HE on one or more occasions during their traineeships.
Three hundred and fifty-nine subjects (81%) had no
HE history up to the time of inclusion. Of these, 78
(22%) developed HE during their traineeships. Among
the subjects with a history of HE but no HE at the time
of inclusion (n=52), 29 (56%) reported HE during one
or more traineeships. Thirty-five subjects (8%) had HE at
the time of inclusion. Mixedmodels analysis showed that,
after adjustment for the effects of exposure, subjects with
a history of HE up to inclusion were at increased risk of
developing HE during traineeships [odds ratio (OR) 4.5;
90%CI2.96–6.98].After taking intoaccountADhistory,
theOR for havingHEduring traineeships for subjectswith
ahistoryofHEwas3.9 (90%CI2.5–6.1).Twenty subjects
who had HE at the time of inclusion also reported HE
during their first traineeship. Because, for these subjects,
it was unknown whether their HE was related to their
traineeshiporwasa continuationof already existingHE, a
second analysis was performed excluding these subjects,
which resulted in an OR of 2.9 (90% CI 1.80–4.70).
Figure 1 shows the prevalence of HE in subjects with
or without a history of HE reported at inclusion, divided
into first and recurrent episodes of HE; it shows the high
prevalence ofHEduring traineeships among subjectswith
ahistoryofHEat inclusionandthehighrecurrencerate for
this group.
The prevalence of HE during the first and second
traineeships in the four subgroups of subjects with or
without AD and FLG mutations is shown in Fig. 2.
Increased prevalence rates of HE were seen for the
FLG−/AD+ subgroup and the FLG+/AD+ subgroup
as compared with the FLG−/AD− control group. Both
Figs. 1 and 2 are restricted to the first and second
traineeships, because the number of subjects who had
completed a third traineeship was too small (n=57) for
subgroup analysis to be performed.
The exposure did not differ appreciably between the
four subgroups; the proportion of subjects who had
traineeships in healthcare sectors with frequent hand
washing (cut-off at >8 times per shift) ranged from 63%
to 71%.
The effects of AD, FLGmutations and exposure on the
risk of developing HE during traineeships were calculated
with a mixed models design. On the basis of the results of
Part I of this study (42), the frequency of hand washing
during traineeships, hand washing at home >10 times
a day and working in a side job involving wet work (e.g.
healthcare, bars, or restaurants) were included in the
models to account for wet work exposure. A first crude
analysis resulted in an unadjusted OR of 1.1 (90% CI
0.7–2.0) for FLGmutations and an unadjusted OR of 2.8
(90% CI 1.9–4.1) for AD.
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
Contact Dermatitis, 70, 139–150 143
SUSCEPTIBILITY TO HAND ECZEMA IN APPRENTICE NURSES • VISSER ET AL.
Ta
b
le
2.
N
u
m
be
ro
fa
pp
re
n
ti
ce
n
u
rs
es
re
po
rt
in
g
h
av
in
g
(o
rh
av
in
g
h
ad
)s
ym
pt
om
so
fh
an
d
ec
ze
m
a
at
in
cl
u
si
on
,a
n
d
re
la
ti
ve
ri
sk
(R
R
)r
at
io
sf
or
sy
m
pt
om
so
fh
an
d
ec
ze
m
a
in
fo
u
rs
u
bg
ro
u
ps
ba
se
d
on
fil
ag
gr
in
ge
n
e
F
LG
m
u
ta
ti
on
s
an
d
h
is
to
ry
of
at
op
ic
de
rm
at
it
is
(A
D
)
Su
bg
ro
up
na
m
e:
FL
G
−/
A
D
−
FL
G
+/
A
D
−
FL
G
−/
A
D
+
FL
G
+/
A
D
+
Su
bg
ro
up
ch
ar
ac
te
ris
tic
s
(R
ef
er
en
ce
)
RR
RR
RR
RR
RR
FL
G
m
ut
at
io
ns
a
H
is
to
ry
of
A
D
b
N
o
N
o
Y
es N
o
N
o
Y
es
Y
es
Y
es
FL
G
+/
A
D
−
ve
rs
us
FL
G
−/
A
D
−
FL
G
−/
A
D
+
ve
rs
us
FL
G
−/
A
D
−
FL
G
+/
A
D
+
ve
rs
us
FL
G
−/
A
D
−
FL
G
+/
A
D
+
ve
rs
us
FL
G
+/
A
D
−
FL
G
+/
A
D
+
ve
rs
us
FL
G
−/
A
D
+
N
=
40
5
N
=
38
N
=
12
5
N
=
28
Re
po
rt
ed
sy
m
pt
om
s
on
th
e
ha
nd
s/
fin
ge
rs
at
in
cl
us
io
n
n
(%
)
n
(%
)
n
(%
)
n
(%
)
RR
(9
0%
C
I)
RR
(9
0%
C
I)
RR
(9
0%
C
I)
RR
(9
0%
C
I)
RR
(9
0%
C
I)
Re
dn
es
s
84
(2
1)
7
(1
8)
60
(4
8)
16
(5
7)
0.
9
(0
.5
0
–
1.
59
)
2.
3*
(1
.8
5
–
2.
89
)
2.
8*
(2
.0
1
–
3.
77
)
3.
1*
(1
.4
8
–
6.
51
)
1.
2
(0
.8
7
–
1.
62
)
Sc
al
in
g
88
(2
2)
5
(1
3)
47
(3
8)
15
(5
4)
0.
6
(0
.3
0
–
1.
22
)
1.
7*
(1
.3
5
–
2.
21
)
2.
5*
(1
.7
8
–
3.
42
)
4.
1*
(1
.6
8
–
9.
88
)
1.
4*
(1
.0
1
–
2.
01
)
Itc
hi
ng
14
5
(3
6)
14
(3
7)
74
(5
9)
18
(6
4)
1.
0
(0
.7
1
–
1.
48
)
1.
7*
(1
.4
0
–
1.
95
)
1.
8*
(1
.3
9
–
2.
32
)
1.
7*
(1
.0
6
–
2.
88
)
1.
1
(0
.8
4
–
1.
41
)
Fi
ss
ur
es
91
(2
2)
11
(2
9)
46
(3
7)
15
(5
4)
1.
3
(0
.8
3
–
2.
01
)
1.
6*
(1
.2
8
–
2.
09
)
2.
4*
(1
.7
2
–
3.
31
)
1.
9*
(1
.0
1
–
3.
39
)
1.
5*
(1
.0
3
–
2.
06
)
V
es
ic
le
s
48
(1
2)
0
(0
)
32
(2
6)
8
(2
9)
–
2.
2*
(1
.5
4
–
3.
02
)
2.
4*
(1
.4
1
–
4.
14
)
n.
a.
1.
1
(0
.6
4
–
1.
94
)
Bu
m
ps
74
(1
8)
2
(5
)
46
(3
7)
9
(3
2)
0.
3*
(0
.0
9
–
0.
91
)
2.
0*
(1
.5
5
–
2.
61
)
1.
8*
(1
.0
8
–
2.
85
)
6.
1*
(1
.4
3
–
26
.1
0)
0.
9
(0
.5
3
–
1.
43
)
H
is
to
ry
of
m
ild
ha
nd
ec
ze
m
ac
16
3
(4
0)
13
(3
4)
81
(6
5)
19
(6
8)
0.
9
(0
.5
8
–
1.
25
)
1.
6*
(1
.3
9
–
1.
87
)
1.
7*
(1
.3
3
–
2.
13
)
2.
0*
(1
.1
9
–
3.
30
)
1.
1
(0
.8
2
–
1.
33
)
H
is
to
ry
of
ha
nd
ec
ze
m
ad
54
(1
3)
2
(5
)
37
(3
0)
12
(4
3)
0.
4
(0
.1
2
–
1.
25
)
2.
2*
(1
.6
3
–
3.
02
)
3.
2*
(2
.1
2
–
4.
87
)
8.
1*
(1
.9
8
–
33
.5
2)
1.
5
(0
.9
5
–
2.
21
)
M
ild
ha
nd
ec
ze
m
a
cu
rr
en
tly
pr
es
en
t
58
(1
4)
7
(1
8)
32
(2
6)
9
(3
2)
1.
3
(0
.7
1
–
2.
33
)
1.
8*
(1
.3
0
–
2.
46
)
2.
2*
(1
.3
7
–
3.
68
)
1.
7
(0
.7
4
–
4.
12
)
1.
3
(0
.7
5
–
2.
10
)
H
an
d
ec
ze
m
a
cu
rr
en
tly
pr
es
en
t
18
(4
)
1
(3
)
14
(1
1)
7
(2
5)
0.
6
(0
.1
1
–
3.
14
)
2.
5*
(1
.4
4
–
4.
42
)
5.
6*
(2
.9
1
–
10
.8
7)
9.
5*
(1
.2
4
–
72
.8
9)
2.
2*
(1
.1
3
–
4.
40
)
C
I,
co
n
fid
en
ce
in
te
rv
al
.
a
C
ar
ri
er
of
on
e
or
m
or
e
of
th
e
fo
llo
w
in
g
lo
ss
-o
f-
fu
n
ct
io
n
m
u
ta
ti
on
s
in
F
LG
:R
5
0
1
X
,2
2
8
2
de
l4
,R
2
4
4
7
X
,o
r
S3
2
4
7
X
.
b
A
h
is
to
ry
of
A
D
w
as
as
se
ss
ed
by
qu
es
ti
on
n
ai
re
,w
it
h
a
sl
ig
h
tl
y
m
od
ifi
ed
ve
rs
io
n
of
th
e
U
K
W
or
ki
n
g
P
ar
ty
cr
it
er
ia
.
c O
n
e
or
m
or
e
of
th
e
fo
llo
w
in
g
co
m
bi
n
at
io
n
s
of
sy
m
pt
om
s:
re
dn
es
s
an
d
it
ch
,r
ed
n
es
s
an
d
sc
al
in
g,
sc
al
in
g
an
d
it
ch
,fi
ss
u
re
s
an
d
re
dn
es
s,
fis
su
re
s
an
d
it
ch
,fi
ss
u
re
s
an
d
sc
al
in
g,
ve
si
cl
es
,o
r
pa
pu
le
s.
d
O
n
e
or
m
or
e
of
th
e
fo
llo
w
in
g
co
m
bi
n
at
io
n
s
of
sy
m
pt
om
s:
fis
su
re
s
an
d
re
dn
es
s,
fis
su
re
s
an
d
it
ch
,fi
ss
u
re
s
an
d
sc
al
in
g,
ve
si
cl
es
,o
r
pa
pu
le
s,
pl
u
s
du
ra
ti
on
of
>
3
da
ys
or
re
cu
rr
en
ce
(s
ym
pt
om
s
re
po
rt
ed
m
or
e
th
an
on
ce
).
* S
ig
n
ifi
ca
n
ta
tα
<
0
.0
5
.
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
144 Contact Dermatitis, 70, 139–150
SUSCEPTIBILITY TO HAND ECZEMA IN APPRENTICE NURSES • VISSER ET AL.
Fig. 1. Reported period prevalence of hand eczema (HE) during traineeships in the first and second years of follow-up in subjects with or
without a history of HE reported at inclusion.
Fig. 2. Reported period prevalence of hand eczema (HE) during the first and second traineeships in four subgroups of participants. *p<0.05;
***p<0.0001.
Table 3 shows the results of two multivariate
mixed models including the four susceptibility subgroups
together with exposure; in both models, the occurrence
of mild HE in FLGwild-type subjects without AD serves as
the reference.Model1 shows that, after adjustment for the
effects of exposure, a history of AD and the combination of
ahistoryofADandFLGmutations increased the risk ofHE
during vocational training with ORs, respectively, of 2.2
and3.6.Taking intoaccount thegroupsizes, theweighted
OR of AD was 2.5 (90% CI 1.7–3.7). For mild HE, the
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Table 3. Multivariate mixedmodels including atopic dermatitis (AD), filaggrin gene FLG loss-of-functionmutations and exposure to frequent
hand washing as risk factors for hand eczema (HE) during traineeships
Model 1 Model 2
Mild HE during practical
training
HE during practical
training
HE during practical training in
subjects without previous wet
work exposure and with no
history of HE up to inclusion
No. of subjects included – 448 448 247
No. of exposure records – 667 667 375
Factor – OR (expβ) (90% CI) OR (expβ) (90% CI) OR (expβ) (90% CI)
FLG mutations and AD FLG: no AD: no 1.0 (reference) 1.0 (reference) 1.0 (reference)
FLG: yes AD: no 0.9 (0.4–1.8) 0.7 (0.3–1.7) 0.5 (0.1–1.9)
FLG: no AD: yes 2.1 (1.0–3.1)* 2.2 (1.4–3.4)* 1.4 (0.7–2.9)
FLG: yes AD: yes 2.1 (1.0–4.0)* 3.6 (1.7–7.5)* 3.7 (1.0–13.5)
Frequent hand washing during
traineeships (>8 times per shift)a
Yes versus no 1.4 (0.9–2.3) 2.2 (1.2–4.2)* 1.4 (0.6–3.4)
Frequent hand washing at home
(>10 times per day)
Yes versus no 1.8 (1.2–2.8)* 1.8 (1.1–2.9)* 1.9 (0.9–4.2)
Working in a side job involving wet
work for >8hr/week
Yes versus no 1.6 (1.2–2.3)* 1.0 (0.7–1.5) 1.2 (0.6–2.1)
CI, confidence interval; OR, odds ratio.
aBased on the healthcare sector means of reported frequency of hand washing on exposure cards.
*p<0.05.
corresponding ORs were both 2.1. For FLG mutations in
subjects without a history of AD, no effect could be shown
(OR 0.7). Frequent hand washing during traineeships
(>8 times per shift) and frequent hand washing at home
(>10 times per day) increased the risk of hand eczema,
with ORs of 2.2 and 1.8, respectively.
Model 2 concerns HE during traineeships in subjects
who had been free from HE up to inclusion, and who
had not been exposed to skin irritants before entering the
study (e.g. previous education or career involving wet
work or traineeships in previous school years, because
the extent of that exposure could not be estimated). A
similar tendency for an increased risk of HEwas found for
AD in combination with FLGmutations and for frequent
hand washing at home.
As these results suggest that the influence of FLG
mutations on HE differs between subjects with and
withoutAD,we investigated theexistenceof interaction in
a model including FLG, AD, an interaction term between
FLG and AD, and exposure. In the model including all
participants (Model 1), no significant interaction effect
couldbeshown[OR(interaction)2.1;90%CI0.6–7.1]. In
themodel including only subjects without previous HE or
exposure (Model 2), a tendency (p=0.08) for interaction
was found [OR (interaction) 5.4; 90% CI 1.1–25.9].
Use of hand cream
Use of hand cream at least once a day was reported by
53% of the subjects in the FLG−/AD− subgroup. The use
of hand cream was significantly more frequent than this
in the FLG−/AD+ subgroup (68%, chi-square, p=0.04)
and in the FLG+/AD+ subgroup (90%, p=0.006), but
not in the FLG+/AD− subgroup (62%, p=0.190).
Discussion
This study examined both genetic susceptibility and
environmental exposure as risk factors for HE. Regarding
AD, we found a distinct effect on HE with both the follow-
up and the retrospective approaches. During follow-up,
we foundno indicationof an increased riskofHEconferred
by FLG loss-of-function mutations, although the subjects
with FLG mutations in addition to a history of AD had
the highest OR for HE during traineeships (OR 3.6). With
the retrospective approach, FLG mutations only had an
effect on HE at inclusion in subjects with AD. Frequent
hand washing during traineeships (>8 times per shift)
or at home (>10 times per day) increased the risk of HE
during follow-up, with ORs of 2.2 and 1.8, respectively.
Our results confirm that a history of AD is associated
with an increased risk of HE in high-risk occupations,
a finding that has been made in several epidemiological
studies (45–49).
The fact that we could not show an effect of FLGmuta-
tions in the present study was unexpected. The high OR
for HE during traineeships among subjects with concomi-
tant FLGmutations and AD is consistent with the results
of our recent case–control study on occupational contact
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
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dermatitis patients and vocational students in training
for high-risk occupations. In that study, an effect of FLG
mutations irrespective of AD (OR 1.6; 95% CI 1.0–2.6)
was found (34). The cases in that study, however, had
chronic and severe HE, as opposed to the apprentice
nurses, who often had less severe HE, which might not
become chronic. Possibly, higher exposure or a longer
duration is needed to reveal an effect of FLGmutations.
In a recent cross-sectional population study, Thyssen
et al. found that FLG mutations constituted a risk factor
for HE in individuals with AD, but not in individuals
without AD (33). Our data also point to an interactive
effect, although this was only indicated in part of the
analyses (Model 2).
The absence of a significant effect of FLG mutations
in this study could not be explained by differences in
exposure or use of hand cream. A possible explanation
might be that that some FLG mutation carriers are able
to compensate for reduced amounts of filaggrin in their
skin via an as yet unknownmechanism, preventing them
fromdevelopingADaswell asHE. Thismaypartly explain
the wide range in susceptibility to HE (OR 0.7–3.6) that
we observed among FLG mutation carriers, which – in
view of the observed tendency for interaction – is partly
related to the absence or presence of AD. More research
into the skin barrier properties of FLG mutation carriers
without ADmay shed more light on this.
Irrespective of FLG mutations, a possible role of the
filaggrin protein itself may be considered. Recently,
one study investigated skin lipid composition, irritation
response and the skin barrier in AD patients and controls,
both with and without FLG mutations. No differences
in stratum corneum lipid composition or increases in
transepidermal water loss after a 24-hr irritation test
were found betweenFLGmutation carriers andFLGwild-
type individuals (50). Another recent study also found no
difference in lipid composition and skin barrier function
between AD patients with and without FLG mutations.
However, there was a significant positive correlation
between favourable lipid organization and skin barrier
function and natural moisturizing factors (NMFs) in the
stratum corneum (51). As NMFs can be seen as a proxy
for filaggrin expression (52, 53), this might imply that
filaggrin itself does play a role in the stratum corneum
lipid composition and skin barrier function. Indeed,
research among ichthyosis vulgaris patients carrying
FLG mutations showed that filaggrin deficiency led to
a paracellular defect in skin barrier function, caused by
disrupted lipid bilayer organization and altered loading of
lamellar bodies (25). In addition to the loss-of-function
mutations, several other factors, mostly associated with
AD, can influence filaggrin levels in the skin. For instance,
the expression of filaggrin may be downregulated by
inflammatory cytokines, for example interleukin (IL)-4,
IL-13, IL-22, and IL-25 (37, 54–56). Also, Brown et al.
have recently shown that the number of filaggrin repeats
in the FLG gene may vary between 10, 11 and 12,
and that these copy number variations are significantly
associated with the risk of AD (57). It might be speculated
that variation in filaggrin expression caused by copy
number variations may also play a role in susceptibility
to occupational HE. Future studies investigating the
role of filaggrin in occupational HE should consider
the inclusion of copy number variations in their
analysis.
Some limitations of this study need to be mentioned.
First, because of the multiple traineeships in which
participants were repeatedly at risk of HE, a mixed
model analysis was used. We note that the ORs obtained
from the models are an overestimation of the RRs. This
especially applies to subgroups with a high prevalence of
HE. Corresponding RRs can be calculated by using the
estimated means obtained from the models. For example,
in Model 1, the ORs for HE of 0.7, 2.2 and 3.6 for
the FLG+/AD−, FLG−/AD+ and FLG+/AD+ subgroups
correspond to RRs of, respectively, 0.7, 1.9, and 2.5.
Second, detailed information on wet work exposure
was available for only 383 of the 446 subjects who were
followed up in this cohort. Repeating the mixed models
analysis in this subset of subjects yielded similar results as
when all subjects were included, which justifies the use of
extrapolated exposure variables.
A third limitation is that, on the basis of the symptoms
as reported, we were not able to distinguish between HE
of the irritant, allergic or atopic type. Despite a similar
clinical appearance, these subtypes of HE have different
underlying mechanisms, and are probably not equally
affected by genetic susceptibility factors. For example,
FLG loss-of-function mutations have shown positive
associations with irritant dermatitis (32, 40), but less
so with allergic contact dermatitis (31, 39). Patch testing
would be needed to differentiate between subjects with
irritant HE and those with allergic HE, but this was not
feasible inour study.Among the52subjectswith reported
symptoms of HE who were seen by the collaborating
occupational physician, contact allergy was diagnosed
in, at most, 23% (Part I) (42). If we had been able to
exclude the cases with contact allergy from our study,
this would probably have shifted the ORs for HE resulting
from FLG mutations a little away from 1. Also, we were
not able to assess severity of HE on the basis of the self-
reported symptoms. The use of hand cream by 90% of the
subjects in the FLG+/AD+ subgroup, however, suggests
more severeHE in this subgroup.Possibly, a strongereffect
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
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of FLG mutations would have been found in association
with severity of HE.
One of the underlying reasons for this study was to
investigate whether adding FLG genotyping to the AD
screening tool would improve the identification of suscep-
tible individuals in high-risk occupations. Our results do
not convincingly indicate that this is the case. Even if the
effect of FLG mutations in subjects with a history of AD
had been significant, the effect size would probably be too
small for a substantial favourable effect on the predictive
values of a screening procedure. Information about AD
and HE history, as is currently asked for according to
Dutch and German guidelines, is a feasible predictor for
the acquisition of occupational HE, as our results have
confirmed. The results of our case–control study (34)
and our present prospective cohort study show that those
in the FLG+/AD+ subgroup are at the highest risk for
ocupational HE. Furthermore, occupational HE patients
with concomitant AD and FLG mutations appeared to
have a worse prognosis than FLG−/AD−, FLG−/AD+
or FLG+/AD− patients in a recent follow-up study (58).
New research might confirm that AD patients with FLG
mutations are indeed substantially more susceptible to
occupational HE than patients with AD without FLG
mutations. If this is so, identifying FLGmutations among
AD patients and advising avoidance of irritant exposure
in such patients would be beneficial.
Conclusion and Recommendations
A history of AD, a history of HE and wet work exposure
were the most important factors increasing the risk of
HE during traineeships. As our results confirm that HE
develops shortly after the start of exposure to wet work,
even in traineeships, it is strongly recommended to start
prevention programmes as early as during vocational
training, insteadof at the timeof employment. Inaddition,
it would be interesting to further investigate the skin
barrier properties of FLG mutation carriers without AD,
which may shed more light on the existence of possible
mechanisms to compensate for reduced filaggrin in
the skin.
Acknowledgements
We would like to thank the Hogeschool van Amsterdam,
Hogeschool INHolland Amsterdam & Alkmaar, ROC van
Amsterdam, ROC ASA Amsterdam, Hogeschool Utrecht,
ROC MiddenNederland Utrecht, Hogeschool Rotterdam,
Albeda College Rotterdam, Hogeschool Leiden, HAN
Nijmegen, Hanzehogeschool Groningen, Noorderpoort
College Groningen, Christelijke Hogeschool Ede and
ROC Novacollege Haarlem for their kind cooperation,
and their students for their participation in this study.
We appreciate support from the COST Action BM0903
SKINBAD (Skin Barrier in Atopic Diseases). Furthermore,
we thank N. van Geloven and Professor Dr A. H.
Zwinderman, AMC Clinical Research Unit, Academic
Medical Centre, Amsterdam, for their excellent statistical
assistance. We are also grateful to La Roche-Posay and
STOKO® Skin Care, who enabled us to give small gifts to
the participants.
References
1 Nicholson P J, Llewellyn D, English J S.
Evidence-based guidelines for the
prevention, identification and
management of occupational contact
dermatitis and urticaria. Contact
Dermatitis 2010: 63: 177–186.
2 van der Meer EW, Boot C R, Jungbauer F
H, van der Klink J J, Rustemeyer T,
Coenraads P J, van der Gulden J W,
Anema J R. Hands4U: a multifaceted
strategy to implement guideline-based
recommendations to prevent hand
eczema in health care workers: design of a
randomised controlled trial and (cost)
effectiveness evaluation. BMC Public
Health 2011: 11: 669.
3 Berndt U, Hinnen U, Iliev D, Elsner P. Role
of the atopy score and of single atopic
features as risk factors for the development
of hand eczema in trainee metal workers.
Br J Dermatol 1999: 140: 922–924.
4 FlyvholmMA, Bach B, Rose M, Jepsen K
F. Self-reported hand eczema in a hospital
population. Contact Dermatitis 2007: 57:
110–115.
5 John S M, Uter W, Schwanitz H J.
Relevance of multiparametric skin
bioengineering in a prospectively-followed
cohort of junior hairdressers. Contact
Dermatitis 2000: 43: 161–168.
6 Schmid K, Broding H C, UterW, Drexler H.
Transepidermal water loss and incidence
of hand dermatitis in a prospectively
followed cohort of apprentice nurses.
Contact Dermatitis 2005: 52: 247–253.
7 Uter W, Pfahlberg A, Gefeller O,
Schwanitz H J. Hand dermatitis in a
prospectively-followed cohort of
hairdressing apprentices: final results of
the POSH study. Prevention of
occupational skin disease in hairdressers.
Contact Dermatitis 1999: 41: 280–286.
8 Meding B, Swanbeck G. Predictive factors
for hand eczema. Contact Dermatitis 1990:
23: 154–161.
9 Nilsson E, Mikaelsson B, Andersson S.
Atopy, occupation and domestic work as
risk factors for hand eczema in hospital
workers. Contact Dermatitis 1985: 13:
216–223.
10 Rystedt I. Factors influencing the
occurrence of hand eczema in adults with
a history of atopic dermatitis in childhood.
Contact Dermatitis 1985: 12: 185–191.
11 Roberts H, Frowen K, SimM, Nixon R.
Prevalence of atopy in a population of
hairdressing students and practising
hairdressers in Melbourne, Australia.
Australas J Dermatol 2006: 47: 172–177.
12 Thyssen J P, Linneberg A, Menne´ T,
Nielsen N H, Johansen J D. The effect of
tobacco smoking and alcohol
consumption on the prevalence of
self-reported hand eczema: a
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
148 Contact Dermatitis, 70, 139–150
SUSCEPTIBILITY TO HAND ECZEMA IN APPRENTICE NURSES • VISSER ET AL.
cross-sectional population-based study. Br
J Dermatol 2010: 162: 619–626.
13 Yngveson M, Svensson A, Johannisson A,
Isacsson A. Hand dermatosis in upper
secondary school pupils: 2-year
comparison and follow-up. Br J Dermatol
2000: 142: 485–489.
14 Angelova-Fischer I, Mannheimer A C,
Hinder A, Ruether A, Franke A, Neubert R
H, Fischer TW, Zillikens D. Distinct barrier
integrity phenotypes in filaggrin-related
atopic eczema following sequential tape
stripping and lipid profiling. Exp Dermatol
2011: 20: 351–356.
15 Jakasa I, de Jongh C M, Verberk MM, Bos J
D, Kezic S. Percutaneous penetration of
sodium lauryl sulphate is increased in
uninvolved skin of patients with atopic
dermatitis compared with control
subjects. Br J Dermatol 2006: 155:
104–109.
16 Jakasa I, Koster E S, Calkoen F, McLeanW
H, Campbell L E, Bos J D, Verberk MM,
Kezic S. Skin barrier function in healthy
subjects and patients with atopic
dermatitis in relation to filaggrin
loss-of-function mutations. J Invest
Dermatol 2011: 131: 540–542.
17 Brown S J, McLeanWH. One remarkable
molecule: filaggrin. J Invest Dermatol
2011: 132, Pt 2: 751–762.
18 Irvine A D, McLeanWH, Leung D Y.
Filaggrin mutations associated with skin
and allergic diseases.N Engl J Med 2011:
365: 1315–1327.
19 O’Regan GM, Irvine A D. The role of
filaggrin in the atopic diathesis. Clin Exp
Allergy 2010: 40: 965–972.
20 Greisenegger E, Novak N, Maintz L et al.
Analysis of four prevalent filaggrin
mutations (R501X, 2282del4, R2447X
and S3247X) in Austrian and German
patients with atopic dermatitis. J Eur Acad
Dermatol Venereol 2010: 24: 607–610.
21 Henderson J, Northstone K, Lee S P et al.
The burden of disease associated with
filaggrin mutations: a population-based,
longitudinal birth cohort study. J Allergy
Clin Immunol 2008: 121: 872–877.
22 Sandilands A, Terron-Kwiatkowski A,
Hull P R et al. Comprehensive analysis of
the gene encoding filaggrin uncovers
prevalent and rare mutations in
ichthyosis vulgaris and atopic eczema.Nat
Genet 2007: 39: 650–654.
23 Schuttelaar M L, Kerkhof M, Jonkman M F
et al. Filaggrin mutations in the onset of
eczema, sensitization, asthma, hay fever
and the interaction with cat exposure.
Allergy 2009: 64: 1758–1765.
24 Scharschmidt T C, Man M Q, Hatano Y
et al. Filaggrin deficiency confers a
paracellular barrier abnormality that
reduces inflammatory thresholds to
irritants and haptens. J Allergy Clin
Immunol 2009: 124: 496–506.
25 Gruber R, Elias P M, Crumrine D et al.
Filaggrin genotype in ichthyosis vulgaris
predicts abnormalities in epidermal
structure and function. Am J Pathol 2011:
178: 2252–2263.
26 Flohr C, England K, Radulovic S, McLean
WH, Campbel L E, Barker J, Perkin M,
Lack G. Filaggrin loss-of-function
mutations are associated with early-onset
eczema, eczema severity and
transepidermal water loss at 3months of
age. Br J Dermatol 2010: 163:
1333–1336.
27 Barker J N, Palmer C N, Zhao Y et al. Null
mutations in the filaggrin gene (FLG)
determine major susceptibility to
early-onset atopic dermatitis that persists
into adulthood. J Invest Dermatol 2007:
127: 564–567.
28 Marenholz I, Nickel R, Ruschendorf F
et al. Filaggrin loss-of-function mutations
predispose to phenotypes involved in the
atopic march. J Allergy Clin Immunol
2006: 118: 866–871.
29 Stemmler S, Parwez Q, Petrasch-Parwez E,
Epplen J T, Hoffjan S. Two common
loss-of-function mutations within the
filaggrin gene predispose for early onset of
atopic dermatitis. J Invest Dermatol 2007:
127: 722–724.
30 Rodriguez E, Baurecht H, Herberich E,
Wagenpfeil S, Brown S J, Cordell H J,
Irvine A D, Weidinger S. Meta-analysis of
filaggrin polymorphisms in eczema and
asthma: robust risk factors in atopic
disease. J Allergy Clin Immunol 2009: 123:
1361–1370.
31 Carlsen B C, Thyssen J P, Menne´ T et al.
Association between filaggrin null
mutations and concomitant atopic
dermatitis and contact allergy. Clin Exp
Dermatol 2011: 36: 467–472.
32 de Jongh C M, Khrenova L, Verberk MM,
Calkoen F, van Dijk F J, Voss H, John S M,
Kezic S. Loss-of-function polymorphisms
in the filaggrin gene are associatedwith an
increased susceptibility to chronic irritant
contact dermatitis: a case–control study.
Br J Dermatol 2008: 159: 621–627.
33 Thyssen J P, Carlsen B C, Menne´ T et al.
Filaggrin null mutations increase the risk
and persistence of hand eczema in subjects
with atopic dermatitis: results from a
general population study. Br J Dermatol
2010: 163: 115–120.
34 Visser M J, Landeck L, Campbell L E,
McLeanWH,Weidinger S, Calkoen F,
John S M, Kezic S. Impact of
loss-of-function mutations in the filaggrin
gene and atopic dermatitis on the
development of occupational irritant
contact dermatitis. Br J Dermatol 2013:
168: 326–332.
35 Bundesanstalt fu¨r Arbeitsschutz und
Arbeitsmedizin. TRGS 401: Risks resulting
from skin contact – determination,
evaluation, measures. 2008. Available at:
http://www.baua.de/cln_135/en/Topics-
from-A-to-Z/Hazardous-Substances/
TRGS/TRGS.html
36 Jungbauer F H, PiebengaW P, ten Berge E
E et al. Guideline Contact
Dermatitis – Prevention, Treatment and
Counselling by the Occupational
PhysicianNVAB Richtlijn
Contacteczeem – Preventie, behandeling
en begeleiding door de bedrijfsarts:
Nederlandse Vereniging voor Arbeids- en
Bedrijfsgeneeskunde (NVAB), April 6,
2006. Available at: http://nvab.art
sennet.nl/Artikel-3/Contacteczeem-
1.htm. (last accessed 21 February
2013).
37 Kim B E, Leung D Y. Epidermal barrier in
atopic dermatitis. Allergy Asthma Immunol
Res 2012: 4: 12–16.
38 Wolf R, Wolf D. Abnormal epidermal
barrier in the pathogenesis of atopic
dermatitis. Clin Dermatol 2012: 30:
329–334.
39 Carlsen B C, Johansen J D, Menne´ T,
Meldgaard M, Szecsi P B, Stender S,
Thyssen J P. Filaggrin null mutations and
association with contact allergy and
allergic contact dermatitis: results from a
tertiary dermatology clinic. Contact
Dermatitis 2010: 63: 89–95.
40 Molin S, Vollmer S, Weiss E H, Ruzicka T,
Prinz J C. Filaggrin mutations may confer
susceptibility to chronic hand eczema
characterized by combined allergic and
irritant contact dermatitis. Br J Dermatol
2009: 161: 801–807.
41 Thyssen J P, Johansen J D, Linneberg A
et al. The association between null
mutations in the filaggrin gene and
contact sensitization to nickel and other
chemicals in the general population. Br J
Dermatol 2010: 162: 1278–1285.
42 Visser M J, Verberk MM, van Dijk F H J,
Bakker J G, Bos J D, Kezic S. Wet work and
hand eczema in apprentice nurses; part I
of a prospective cohort study. Contact
Dermatitis 2014: 70: 44–55.
43 Palmer C N, Irvine A D,
Terron-Kwiatkowski A et al. Common
loss-of-function variants of the epidermal
barrier protein filaggrin are a major
predisposing factor for atopic dermatitis.
Nat Genet 2006: 38: 441–446.
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
Contact Dermatitis, 70, 139–150 149
SUSCEPTIBILITY TO HAND ECZEMA IN APPRENTICE NURSES • VISSER ET AL.
44 Vermeulen R, Kromhout H, Bruynzeel D
P, de Boer E M. Ascertainment of hand
dermatitis using a symptom-based
questionnaire; applicability in an
industrial population. Contact Dermatitis
2000: 42: 202–206.
45 Berndt U, Hinnen U, Iliev D, Elsner P.
Hand eczema in metalworker
trainees – an analysis of risk factors.
Contact Dermatitis 2000: 43: 327–332.
46 Coenraads P J, Diepgen T L. Risk for hand
eczema in employees with past or present
atopic dermatitis. Int Arch Occup Environ
Health 1998: 71: 7–13.
47 Dickel H, Bruckner T M, Schmidt A,
Diepgen T L. Impact of atopic skin
diathesis on occupational skin disease
incidence in a working population. J Invest
Dermatol 2003: 121: 37–40.
48 Lan C C, Tu H P, Lee C H et al. Hand
dermatitis among university hospital
nursing staff with or without atopic
eczema: assessment of risk factors. Contact
Dermatitis 2011: 64: 73–79.
49 Smit H A, van Rijssen A, Vandenbroucke J
P, Coenraads P J. Susceptibility to and
incidence of hand dermatitis in a cohort of
apprentice hairdressers and nurses. Scand J
Work Environ Health 1994: 20: 113–121.
50 Jungersted J M, Scheer H, Mempel M et al.
Stratum corneum lipids, skin barrier
function and filaggrin mutations in
patients with atopic eczema. Allergy 2010:
65: 911–918.
51 Janssens M, van Smeden J, Gooris G S et al.
Increase in short-chain ceramides
correlates with an altered lipid
organization and decreased barrier
function in atopic eczema patients. J Lipid
Res 2012: 53: 2755–2766.
52 Kezic S, Kemperman PM, Koster E S et al.
Loss-of-function mutations in the filaggrin
gene lead to reduced level of natural
moisturizing factor in the stratum
corneum. J Invest Dermatol 2008: 128:
2117–2119.
53 Kezic S, O’Regan GM, Yau N et al. Levels
of filaggrin degradation products are
influenced by both filaggrin genotype and
atopic dermatitis severity. Allergy 2011:
66: 934–940.
54 Gutowska-Owsiak D, Schaupp A L, Salimi
M, Taylor S, Ogg G S. Interleukin-22
downregulates filaggrin expression and
affects expression of profilaggrin
processing enzymes. Br J Dermatol 2011:
165: 492–498.
55 Howell M D, Kim B E, Gao P et al. Cytokine
modulation of atopic dermatitis filaggrin
skin expression. J Allergy Clin Immunol
2007: 120: 150–155.
56 Hvid M, Vestergaard C, Kemp K,
Christensen G B, Deleuran B, Deleuran M.
IL-25 in atopic dermatitis: a possible link
between inflammation and skin barrier
dysfunction? J Invest Dermatol 2011: 131:
150–157.
57 Brown S J, Kroboth K, Sandilands A et al.
Intragenic copy number variation within
filaggrin contributes to the risk of atopic
dermatitis with a dose-dependent effect. J
Invest Dermatol 2012: 132: 98–104.
58 Landeck L, Visser M, Skudlik C, Brans R,
Kezic S, John S M. Clinical course of
occupational irritant contact dermatitis of
the hands in relation to filaggrin genotype
status and atopy. Br J Dermatol 2012:
167: 1302–1309.
© 2013 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
150 Contact Dermatitis, 70, 139–150
